Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
Ann Intern Med
    September 2025
  1. CENTOR RM, Zimetbaum P
    Annals On Call - Atrial Fibrillation: When Ablation Is the Way to Go.
    Ann Intern Med. 2025 Sep 2:e2503841OC. doi: 10.7326/ANNALS-25-03841.
    >> Share

    August 2025
  2. WEITZ HH, Merli GJ, Lip G
    Web Exclusive. Annals Consult Guys - Anticoagulation, Atrial Fibrillation, and Lower Gastrointestinal Bleeding.
    Ann Intern Med. 2025;178:e2503595CG.
    >> Share

    July 2025

  3. Annals Video Summary - Catheter and Surgical Ablation for Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2025 Jul 1:e2502118VS. doi: 10.7326/ANNALS-25-02118.
    >> Share

  4. WAKS JW, Zimetbaum P
    The Significant Benefits of Ablation for Rhythm Control of Atrial Fibrillation.
    Ann Intern Med. 2025 Jul 1. doi: 10.7326/ANNALS-25-02222.
    >> Share

  5. MONTANE B, Zhang S, Wolfe JD, Prime S, et al
    Catheter and Surgical Ablation for Atrial Fibrillation : A Systematic Review and Meta-analysis.
    Ann Intern Med. 2025 Jul 1. doi: 10.7326/ANNALS-25-00253.
    >> Share

    June 2025
  6. KATSANOS AH, Douketis JD
    In survivors of ICH with AF, DOACs reduced incident ischemic stroke and increased recurrent ICH at a median 1.4 y.
    Ann Intern Med. 2025 Jun 3. doi: 10.7326/ANNALS-25-01772.
    >> Share

  7. OGUNTALA JO, Yan AT
    In AF with stable CAD, an OAC alone does not increase ischemic events and reduces major bleeding vs. OAC + SAPT at a mean 22 mo.
    Ann Intern Med. 2025;178:JC65.
    >> Share

    May 2025
  8. ALBERTS MJ
    In patients with subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y in those with previous stroke or TIA.
    Ann Intern Med. 2025 May 6. doi: 10.7326/ANNALS-25-01330.
    >> Share

  9. MANSOOR H, Elgendy IY
    In AF with recent ACS or PCI, apixaban reduced total bleeding vs. VKA; aspirin increased total bleeding vs. placebo at 6 mo.
    Ann Intern Med. 2025;178:JC57.
    >> Share

  10. KHATTAK S, Al-Ansari A, Alfaraidhy M, Rajah F, et al
    Cardiology: What You May Have Missed in 2024.
    Ann Intern Med. 2025;178.
    >> Share

    April 2025
  11. ABDEL-QADIR H, Gunn M, Fang J, Odugbemi T, et al
    Risk for Stroke After Newly Diagnosed Atrial Fibrillation During Hospitalization for Other Primary Diagnoses : A Retrospective Cohort Study.
    Ann Intern Med. 2025 Apr 22. doi: 10.7326/ANNALS-24-01967.
    >> Share

  12. PATEL NS, Joglar JA
    A New Perspective on Atrial Fibrillation "Provoked" by Hospitalization.
    Ann Intern Med. 2025 Apr 22. doi: 10.7326/ANNALS-25-01073.
    >> Share

    March 2025
  13. LADER EW
    In previous MI with ventricular tachycardia (VT), catheter ablation reduced mortality or VT events more than antiarrhythmic drug therapy at 4 y.
    Ann Intern Med. 2025 Mar 4. doi: 10.7326/ANNALS-25-00336.
    >> Share

    February 2025
  14. SMETANA GW, Gelfand EV, Tung P, Burns RB, et al
    How Would You Manage This Patient With Recent-Onset Atrial Fibrillation? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2025 Feb 11. doi: 10.7326/ANNALS-24-03490.
    >> Share

  15. SHARMA M, Srivastava A
    In acute ischemic stroke with AF, early DOAC initiation was noninferior to delayed initiation for ischemic and hemorrhagic outcomes at 90 d.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-03879.
    >> Share

    January 2025
  16. BATES ER
    In subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y, regardless of duration of recent subclinical AF episodes.
    Ann Intern Med. 2025 Jan 7. doi: 10.7326/ANNALS-24-03370.
    >> Share

    November 2024
  17. ROMITI GF, Talerico G
    In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA(2)DS(2)-VASc >4.
    Ann Intern Med. 2024;177:JC125.
    >> Share

    July 2024
  18. SIMON TG, Singer DE, Zhang Y, Mastrorilli JM, et al
    Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
    Ann Intern Med. 2024 Jul 9. doi: 10.7326/M23-3067.
    >> Share

  19. BARNES GD
    In device-detected AF, DOACs vs. aspirin or placebo reduce ischemic stroke and increase major bleeding.
    Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00652.
    >> Share

    June 2024
  20. WEITZ HH, Merli GJ, Lip GYH
    Annals Consult Guys - The ABCs of Atrial Fibrillation.
    Ann Intern Med. 2024;177:e2400618CG.
    >> Share

  21. FIELD TS
    In cryptogenic stroke and atrial cardiopathy, apixaban did not reduce recurrent stroke vs. aspirin.
    Ann Intern Med. 2024;177:JC65.
    >> Share

    May 2024
  22. SPOSATO LA, Hill MD
    In AF, CHA(2)DS(2)-VASc 1 subgroups did not differ for predicting risk for arterial thromboembolism at 1 y.
    Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0023.
    >> Share

  23. DUNN A
    In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo.
    Ann Intern Med. 2024;177:JC57.
    >> Share

    March 2024
  24. SHADRIN IY, Newby LK
    In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 y.
    Ann Intern Med. 2024;177:JC26.
    >> Share

    January 2024
  25. ISHIGUCHI H, Lip GYH
    In symptomatic AF, catheter ablation vs. medical therapy reduced depression and anxiety symptoms at 12 mo.
    Ann Intern Med. 2024 Jan 2. doi: 10.7326/J23-0105.
    >> Share

  26. LOPEZ J, Borzak S
    In noncardiac thoracic surgery, low-dose colchicine did not reduce AF or myocardial injury after noncardiac surgery at 14 d.
    Ann Intern Med. 2024;177:JC3.
    >> Share

    December 2023
  27. BROPHY J
    In symptomatic AF with end-stage HF, adding catheter ablation to medical therapy improved clinical outcomes at 18 mo.
    Ann Intern Med. 2023;176:JC137.
    >> Share

    October 2023
  28. MCINTYRE WF, Vadakken ME, Connolly SJ, Mendoza PA, et al
    Atrial Fibrillation Recurrence in Patients With Transient New-Onset Atrial Fibrillation Detected During Hospitalization for Noncardiac Surgery or Medical Illness : A Matched Cohort Study.
    Ann Intern Med. 2023 Oct 3. doi: 10.7326/M23-1411.
    >> Share

  29. BARNES GD
    In adults, MRAs reduce AF occurrence vs. non-MRAs.
    Ann Intern Med. 2023;176:JC114.
    >> Share

    September 2023
  30. TON IT, Moon J, Sengul A, Mody FV, et al
    Evidence-Based Cardiovascular Disease Medicines' Availability in Low-Cost Generic Drug Programs in the United States : A Cross-Sectional Study.
    Ann Intern Med. 2023 Sep 5. doi: 10.7326/M23-0287.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016